Connection
Laurie Gaspar to Glioma
This is a "connection" page, showing publications Laurie Gaspar has written about Glioma.
|
|
Connection Strength |
|
|
|
|
|
0.868 |
|
|
|
-
Gaspar LE, Zamorano LJ, Shamsa F, Fontanesi J, Ezzell GE, Yakar DA. Permanent 125iodine implants for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 1999 Mar 15; 43(5):977-82.
Score: 0.134
-
Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol. 2015 Jun; 16(6):e270-8.
Score: 0.103
-
Gaspar LE, Fisher BJ, MacDonald DR, LeBer DV, Halperin EC, Schold SC, Cairncross JG. Malignant glioma--timing of response to radiation therapy. Int J Radiat Oncol Biol Phys. 1993 Apr 02; 25(5):877-9.
Score: 0.089
-
Gaspar LE, Cairncross JG. Hyperthermia and brachytherapy for glioma--will cooler heads prevail? Int J Radiat Oncol Biol Phys. 1992; 24(4):803-4; discussion 806-7.
Score: 0.081
-
Gaspar LE, Fisher BJ, Macdonald DR, LeBer DV, Halperin EC, Schold SC, Cairncross JG. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys. 1992; 24(1):55-7.
Score: 0.081
-
Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):51-7.
Score: 0.075
-
Schwer AL, Damek DM, Kavanagh BD, Gaspar LE, Lillehei K, Stuhr K, Chen C. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2008 Mar 15; 70(4):993-1001.
Score: 0.061
-
Zamorano L, Li Q, Tekyi-Mensah S, Gaspar L, Fontanesi J, Levin K. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas. Stereotact Funct Neurosurg. 2003; 81(1-4):10-7.
Score: 0.044
-
Videtic GM, Gaspar LE, Zamorano L, Fontanesi J, Levin KJ, Kupsky WJ, Tekyi-Mensah S. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys. 1999 Oct 01; 45(3):687-92.
Score: 0.035
-
Abdel-Wahab M, Corn B, Wolfson A, Raub W, Gaspar LE, Curran W, Bustillo P, Rubinton P, Markoe A. Prognostic factors and survival in patients with spinal cord gliomas after radiation therapy. Am J Clin Oncol. 1999 Aug; 22(4):344-51.
Score: 0.034
-
Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 1996 Oct 01; 36(3):549-56.
Score: 0.028
-
Kirby S, Macdonald D, Fisher B, Gaspar L, Cairncross G. Pre-radiation chemotherapy for malignant glioma in adults. Can J Neurol Sci. 1996 May; 23(2):123-7.
Score: 0.027
-
Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer. 1996 Apr 15; 77(8):1535-43.
Score: 0.027
-
Archibald YM, Lunn D, Ruttan LA, Macdonald DR, Del Maestro RF, Barr HW, Pexman JH, Fisher BJ, Gaspar LE, Cairncross JG. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg. 1994 Feb; 80(2):247-53.
Score: 0.024
-
Halperin EC, Gaspar L, Imperato J, Salter M, Herndon J, Dowling S. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium. Am J Clin Oncol. 1993 Aug; 16(4):277-83.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|